Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma
Author:
Affiliation:
1. Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
2. Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
Funder
No funding
Publisher
Informa UK Limited
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1933332
Reference60 articles.
1. Renal cell carcinoma
2. EAU Guidelines on Renal Cell Carcinoma: 2014 Update
3. Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer
4. Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data
5. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predicting CTLA4 expression and prognosis in clear cell renal cell carcinoma using a pathomics signature of histopathological images and machine learning;Heliyon;2024-08
2. Network analysis of histopathological image features and genomics data improving prognosis performance in clear cell renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2024-08
3. Multiomics analysis of homologous recombination deficiency across cancer types;Biomolecules and Biomedicine;2024-07-28
4. PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives;Molecular Cancer;2024-07-16
5. FOXM1 transcriptional regulation;Biology of the Cell;2024-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3